1967Defense Technical Information Center (DTIC)Requires access

INHIBITION OF SWEATING BY SCOPOLAMINE.

Craig, F. N., Cummings, E. G., Paul Sussman

Open publisher page 0 citations

Abstract

The purpose of this study was to determine the effects of scopolamine hydrobromide on sweating in man. The methods employed previously with atropine sulfate were applied to scopolamine hydrobromide to compare these two drugs with respect to the dose required to inhibit sweating. Two different sweat rates were obtained by exposing three men at rest to environmental temperatures of 105 and 125 F. The effects of scopolamine on body temperatures, heart rate, and sweating were qualitatively similar to those previously obtained with atropine. It was concluded that scopolamine hydrobromide is from two to three times more potent than atropine sulfate in its effects on sweating and heart rate in man. (Author)

About this research paper

What this paper is about

The purpose of this study was to determine the effects of scopolamine hydrobromide on sweating in man. The methods employed previously with atropine sulfate were applied to scopolamine hydrobromide to compare these two drugs with respect to the dose required to inhibit sweating. Two different sweat rates were obtained by exposing three men at rest to environmental temperatures of 105 and 125 F. The effects of scopolamine on body temperatures, heart rate, and sweating were qualitatively similar to those previously obtained with atropine. It was concluded that scopolamine hydrobromide is from two to three times more potent than atropine sulfate in its effects on sweating and heart rate in man. (Author)

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The purpose of this study was to determine the effects of scopolamine hydrobromide on sweating in man. The methods employed previously with atropine sulfate were applied to scopolamine hydrobromide to compare these two drugs with respect to the dose required to inhibit sweating. Two different sweat rates were obtained by exposing three men at rest to environmental temperatures of 105 and 125 F. The effects of scopolamine on body temperatures, heart rate, and sweating were qualitatively similar to those previously obtained with atropine. It was concluded that scopolamine hydrobromide is from two to three times more potent than atropine sulfate in its effects on sweating and heart rate in man. (Author)

Key concepts: Scopolamine Hydrobromide, Atropine sulfate, Atropine, Scopolamine, SWEAT, Hydrobromide, Heart rate, Parasympatholytic

Related papers

Back to paper searchBrowse research topicsOriginal source
INHIBITION OF SWEATING BY SCOPOLAMINE. — Research Paper | ScholarLens